IRF8 overexpression + ER negative

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

IRF8 overexpression + ER negative	Breast Cancer	IRF8 overexpression + ER negative	Breast Cancer	trastuzumab Sensitive: C3 – Early Trials trastuzumab Sensitive : C3	trastuzumab Sensitive: C3 – Early Trials trastuzumab Sensitive : C3
IRF8 overexpression + ER negative	Breast Cancer	IRF8 overexpression + ER negative	Breast Cancer	Sensitive: C3 – Early Trials Sensitive : C3	Sensitive: C3 – Early Trials Sensitive : C3
IRF8 overexpression + ER negative	Breast Cancer	IRF8 overexpression + ER negative	Breast Cancer	Resistant: C3 – Early Trials Resistant : C3	Resistant: C3 – Early Trials Resistant : C3

Associations